Hypersensitivity reactions and deaths associated with intravenous iron preparations

Abstract

These findings confirm a higher risk for AE, especially serious type 1 reactions, with ID therapy than with newer intravenous iron products and also suggest that IS carries the lowest risk for hypersensitivity reactions.